Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial p... by Zinman, B, Schmidt, W, Moses, A, Lund, N, Gough, S

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial p... by Zinman, B, Schmidt, W, Moses, A, Lund, N, Gough, S

Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies by Zinman, B, Buse, J, Falahati, A, Moses, A, Gough, S

Sex disparities in cardiovascular outcome trials of diabetes populations: a systematic review and meta-analysis by Clemens, K, Woodward, M, Neal, B, Zinman, B, Cheruvath, P

Achieving glycaemic control and weight loss with incretin-based therapies: a comparison of liraglutide, exenatide, and sitagliptin by Zinman, B, Gough, S, Pratley, R, Brett, J, Lund, N, Buse, J

The impact of disease stage, indicated by number of previous oral antidiabetic agents, on the clinical benefits of liraglutide in the treatment of type 2 diabetes by Garber, A, Matthews, D, Zinman, B, Thomsen, AB, Falahati, A, Guerci, B

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss by Schmidt, W, Gough, S, Madsbad, S, Zinman, B, Falahati, A, Toft, A, Sesti, G

Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy. by Ahrén, B, Foley, J, Ferrannini, E, Matthews, DR, Zinman, B, Dejager, S, Fonseca, V

Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride by Ahren, B, Foley, J, Ferrannini, E, Matthews, D, Zinman, B, Dejager, S, Fonseca, V

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and... by Nathan, D, Buse, J, Davidson, M, Heine, R, Holman, R, Sherwin, R, Zinman, B

Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement of the American Diabetes Associat... by Nathan, D, Buse, J, Davidson, M, Ferrannini, E, Holman, R, Sherwin, R, Zinman, B

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy (vol 49, pg 2816, 2006) by Nathan, D, Buse, J, Davidson, M, Heine, R, Holman, R, Sherwin, R, Zinman, B

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from... by Nathan, D, Buse, J, Davidson, M, Ferrannini, E, Holman, R, Sherwin, R, Zinman, B

Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes by Matthews, DR, Marre, M, Le-Thi, T, Zdravkovic, M, Simo, R, Garber, A, Zinman, B

Management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones (Diabetologia... by Nathan, D, Buse, J, Davidson, M, Ferrannini, E, Holman, R, Sherwin, R, Zinman, B

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. by Nathan, D, Buse, J, Davidson, M, Ferrannini, E, Holman, R, Sherwin, R, Zinman, B

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association an... by Nathan, D, Buse, J, Davidson, M, Heine, R, Holman, R, Sherwin, R, Zinman, B

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Associati... by Nathan, D, Buse, J, Davidson, M, Ferrannini, E, Holman, R, Sherwin, R, Zinman, B

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. by Ferrannini, E, Fonseca, V, Zinman, B, Matthews, D, Ahrén, B, Byiers, S, Shao, Q, Dejager, S

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabet... by Nathan, D, Buse, J, Davidson, M, Ferrannini, E, Holman, R, Sherwin, R, Zinman, B